Key Events – And Potential Catalysts – For Biotech Stocks This Week
After a week that saw mostly strong earnings reports from big pharma companies, an Alzheimer’s conference that moved stocks, and a slew of IPOs of…
After a week that saw mostly strong earnings reports from big pharma companies, an Alzheimer’s conference that moved stocks, and a slew of IPOs of…
From traditional “Big Pharma” stocks that have adopted (or are adopting) a greater focus on biotech to large “pure-play” biotech companies to “emerging” biotech stocks…